Balancing the upside and downside of antiretroviral therapy in children.

[1]  Y. Maldonado,et al.  Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. , 2005, JAMA.

[2]  P. Williams,et al.  Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to clinical practice. , 2005, JAMA.

[3]  L. Mofenson,et al.  A trial of three antiretroviral regimens in HIV-1-infected children. , 2004, The New England journal of medicine.

[4]  L. D'Angelo,et al.  A family group approach to increasing adherence to therapy in HIV-infected youths: results of a pilot project. , 2003, AIDS patient care and STDs.

[5]  A. Wu,et al.  Adherence to Antiretroviral Therapy: Where Are We, and Where Do We Go From Here? , 2002, Journal of acquired immune deficiency syndromes.

[6]  D. Vlahov,et al.  A PROSPECTIVE STUDY OF ADHERENCE AND VIRAL LOAD IN A LARGE MULTI-CENTER COHORT OF HIV-INFECTED WOMEN , 2002, AIDS.

[7]  V. Stone,et al.  Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  E. Morse,et al.  Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. , 2002, Pediatrics.

[9]  V. Idemyor.  Continuing debate over HIV therapy initiation , 2002, HIV clinical trials.

[10]  D. Murphy,et al.  The TREAT (Therapeutic Regimens Enhancing Adherence in Teens) program: theory and preliminary results. , 2001, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[11]  J. Church.  Reducing the Odds — Preventing Transmission of HIV in the United States , 2001, Journal of Perinatology.

[12]  P. Sriskandabalan,et al.  Self-medication with zidovudine that was not , 2001, The Lancet.

[13]  K. Hertogs,et al.  High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Côte d'Ivoire. , 2001 .

[14]  G. Zissis,et al.  Effectiveness of antiretroviral therapy initiated before the age of 2 months in infants vertically infected with human immunodeficiency virus type 1 , 2000, European Journal of Pediatrics.

[15]  Susan Swindells,et al.  Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.

[16]  S. Lee,et al.  Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team. , 2000, JAMA.

[17]  G. Luftman,et al.  Antiretroviral adherence issues among HIV-positive adolescents and young adults. , 1999, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[18]  J. Farley,et al.  Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1. , 1999, The Pediatric infectious disease journal.

[19]  M. Gersten,et al.  Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  M. Gwinn,et al.  Projection of AIDS and HIV incidence among children born infected with HIV. , 1998, Statistics in medicine.